Evidence map›Paper›PMID 38585781›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease.

Tanner D Jensen, Bohan Ni, Chloe M Reuter, John E Gorzynski, Sarah Fazal, Devon Bonner, Rachel A Ungar, Pagé C Goddard, Archana Raja, Euan A Ashley and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Tanner D JensenStanford University.ORCID 0000-0002-1873-8607
Bohan NiJohns Hopkins University.ORCID 0000-0002-8570-6103
Chloe M ReuterStanford Health Care.
John E GorzynskiStanford University.ORCID 0000-0002-9034-9016
Sarah FazalUniversity of Miami.ORCID 0000-0001-9064-6152
Devon BonnerStanford Health Care.ORCID 0000-0002-8771-0886
Rachel A UngarStanford University.ORCID 0000-0002-2214-959X
Pagé C GoddardStanford University.ORCID 0000-0001-8187-5316
Archana RajaStanford University.ORCID 0000-0001-7079-9872
Euan A AshleyStanford University.ORCID 0000-0001-9418-9577
Jonathan A BernsteinStanford University.ORCID 0000-0001-5369-346X
Stephan ZuchnerStanford University.ORCID 0000-0002-8498-5235
Undiagnosed Diseases Network
Michael D GreiciusStanford University.ORCID 0000-0002-5462-9037
Stephen B MontgomeryStanford University.ORCID 0000-0002-5200-3903
Michael C SchatzJohns Hopkins University.ORCID 0000-0002-4118-4446
Matthew T WheelerStanford Center for Inherited Cardiovascular Disease.ORCID 0000-0001-8721-3022
Alexis BattleJohns Hopkins University.ORCID 0000-0002-5287-627X
Stanford University · USJohns Hopkins University · USStanford Health Care · USUniversity of Miami · US

Funding

INSTITUTIONAL TRAINING GRANT IN GENOME SCIENCET32HG000044 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL P. SNYDER · 1995 to 2026
$32.2M
Stanford Alzheimer's Disease Research CenterAdmin Supp: Developing iPSC models for AD and PDP30AG066515 · NIA · STANFORD UNIVERSITY · PI Lisa Goldman Rosas · 2020 to 2026
$29.0M
Implementing the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)U24HG010263 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI Enis Afgan, VINCENT JAMES CAREY · 2018 to 2026
$23.8M
NIH Cloud Platform Interoperability Administrative Coordinating CenterOT2OD034190 · OD · RESEARCH TRIANGLE INSTITUTE · PI ROBBINS, ELIZABETH · 2022 to 2023
$16.9M
Stanford Mendelian Genomics Research CenterU01HG011762 · NHGRI · STANFORD UNIVERSITY · PI Jonathan Adam Bernstein, Stephen Montgomery · 2021 to 2026
$16.7M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologiesU01AG072573 · NIA · STANFORD UNIVERSITY · PI KUNDAJE, ANSHUL, MONTGOMERY, STEPHEN · 2021 to 2025
$8.3M
What comes next? Engaging stakeholders in governance of participant data and relationships during the sunset of large genomic medicine research initiativesU01HG010218 · NHGRI · STANFORD UNIVERSITY · PI ASHLEY, EUAN A, BERNSTEIN, JONATHAN ADAM · 2018 to 2022
$6.3M
Hippocampal-dependent memory decline in aging and early Alzheimer's diseaseR01AG074339 · NIA · STANFORD UNIVERSITY · PI ELIZABETH MORMINO · 2022 to 2026
$6.0M
Illuminating the APOE Locus with Long-Read Sequencing and Targeted GenomicsR35AG072290 · NIA · STANFORD UNIVERSITY · PI GREICIUS, MICHAEL D · 2021 to 2025
$4.6M
Predicting context-specific molecular and phenotypic effects of genetic variation through the lens of the cis-regulatory codeU01HG012069 · NHGRI · STANFORD UNIVERSITY · PI Anshul Kundaje · 2021 to 2026
$3.9M
Mapping Molecular and Phenotypic Interactions in Alzheimers DiseaseR01AG066490 · NIA · STANFORD UNIVERSITY · PI MONTGOMERY, STEPHEN · 2020 to 2024
$3.6M
NCI NIH HHS R03 CA272952NCI NIH HHS U01 CA253481NHGRI NIH HHS R21 HG013397NHGRI NIH HHS T32 HG000044NHGRI NIH HHS U01 HG010218NHGRI NIH HHS U01 HG011762NHGRI NIH HHS U01 HG012069NHGRI NIH HHS U24 HG010263NIA NIH HHS R01 AG048076NIA NIH HHS R01 AG066490NIA NIH HHS R01 AG074339NIA NIH HHS R35 AG072290NIA NIH HHS U01 AG072573NIGMS NIH HHS R35 GM139580NIH HHS OT2 OD034190NIH HHS S10 OD025082NIMH NIH HHS R01 MH125244NINDS NIH HHS R01 NS072248NINDS NIH HHS U01 NS134358
6 · The paper itself

Abstract

Rare structural variants (SVs) - insertions, deletions, and complex rearrangements - can cause Mendelian disease, yet they remain difficult to accurately detect and interpret. We sequenced and analyzed Oxford Nanopore long-read genomes of 68 individuals from the Undiagnosed Disease Network (UDN) with no previously identified diagnostic mutations from short-read sequencing. Using our optimized SV detection pipelines and 571 control long-read genomes, we detected 716 long-read rare (MAF < 0.01) SV alleles per genome on average, achieving a 2.4x increase from short-reads. To characterize the functional effects of rare SVs, we assessed their relationship with gene expression from blood or fibroblasts from the same individuals, and found that rare SVs overlapping enhancers were enriched (LOR = 0.46) near expression outliers. We also evaluated tandem repeat expansions (TREs) and found 14 rare TREs per genome; notably these TREs were also enriched near overexpression outliers. To prioritize candidate functional SVs, we developed Watershed-SV, a probabilistic model that integrates expression data with SV-specific genomic annotations, which significantly outperforms baseline models that don't incorporate expression data. Watershed-SV identified a median of eight high-confidence functional SVs per UDN genome. Notably, this included compound heterozygous deletions in

Identifiers

PMID38585781
PMCPMC10996727
OpenAlexW4393180342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.